U.S. Stem Cell Clinics and International Businesses Are Registering For-Profit, Pay-to-Participate “Studies” on ClinicalTrials.gov

Written by Regenerative Medicine

New perspective piece highlights the regulatory, ethical and scientific issues associated with U.S. “stem cell clinics” registering pay-to-participate stem cells studies on the NIH registry and database, ClinicalTrials.gov. The Future Science Group (FSG) journal Regenerative Medicine, has announced the publication of a new Perspective article, in which Leigh Turner (University of Minnesota, MN, USA) discusses the urgent need for careful screening of clinical trials prior to registration with ClinicalTrials.gov in order to improve patient safety.   In the article, Turner discusses how U.S. clinics and international businesses that engage in direct-to-consumer advertising of purported stem cell treatments are successfully registering...

To view this content, please register now for access

It's completely free